Hypokalemia
Hypokalemia is a serum potassium concentration <3.5 mmol/L (mEq/L). It reflects either a true deficit of total-body potassium or a shift of potassium from the blood into cells. It is clinically important because it can impair neuromuscular function and trigger potentially dangerous cardiac arrhythmias.
Severity
- Mild: 3.0 to 3.4 mmol/L
- Moderate: 2.5 to 2.9 mmol/L
- Severe: <2.5 mmol/L
Urgency depends not only on the number but also on symptoms, ECG findings, rate of fall, ongoing losses, and cardiac risk factors.
Causes
Think in three categories:
-
Reduced intake
- Poor nutrition or starvation
- Usually contributes rather than causes marked hypokalemia by itself, unless combined with other losses
-
Potassium loss
- Gastrointestinal: diarrhea, vomiting or nasogastric suction, laxative use, intestinal fistulas
- Renal: loop or thiazide diuretics, mineralocorticoid excess, renal tubular disorders, magnesium deficiency, some drugs such as amphotericin B
- Vomiting causes renal potassium wasting indirectly through volume depletion, metabolic alkalosis, and increased aldosterone.
-
Shift into cells, without necessarily losing total-body potassium
- Insulin administration
- Beta-2 agonists, for example salbutamol/albuterol
- Alkalosis
- Thyrotoxic or familial periodic paralysis
- Catecholamine excess
Insulin, beta-adrenergic stimulation, thyroid hormone, and alkalosis promote cellular potassium uptake through Na+/K+-ATPase activity. Harrison’s Principles of Internal Medicine, 22nd ed., pp. 398-472.
Symptoms and signs
Many people with mild hypokalemia have no symptoms. More marked deficiency may cause:
- Fatigue, muscle cramps, myalgia
- Muscle weakness, which can progress to flaccid paralysis
- Constipation, ileus, or urinary retention
- Polyuria and polydipsia due to impaired renal concentrating ability
- Rhabdomyolysis in severe cases
- Respiratory muscle weakness or respiratory failure in extreme cases
- Palpitations, syncope, or arrhythmia
Hypokalemia increases the risk of both atrial and ventricular arrhythmias and heightens susceptibility to digoxin toxicity. Harrison’s Principles of Internal Medicine, 22nd ed., pp. 398-472.
ECG findings
Typical progression includes:
- Flattened or inverted T waves
- ST-segment depression
- Prominent U waves
- Apparent QT prolongation, often actually QU prolongation
- Ventricular ectopy and tachyarrhythmias when severe
ECG changes do not correlate perfectly with the potassium level. A normal ECG does not eliminate risk.
Evaluation
-
Confirm the result
- Repeat serum potassium if unexpected, to exclude laboratory error or pseudohypokalemia.
-
Assess urgency
- Symptoms, ECG, cardiac history, digoxin use, kidney function, and ongoing losses.
- Obtain an ECG in clinically significant hypokalemia.
-
Check associated tests
- Magnesium, bicarbonate or blood gas, glucose, creatinine, and often phosphate.
- Correct magnesium deficiency, because low magnesium promotes renal potassium wasting and can make hypokalemia refractory to treatment.
-
Determine whether losses are renal
- If the cause is unclear, assess urinary potassium.
- Low urinary potassium in hypokalemia suggests an appropriate renal response, favoring gastrointestinal loss, poor intake, or a cellular shift.
- Inappropriately high urinary potassium suggests renal wasting, such as diuretics, mineralocorticoid excess, or tubulopathies.
- Acid-base status and blood pressure then help narrow the cause.
A practical diagnostic approach includes serum magnesium and urinary potassium measurement when the history does not reveal the mechanism, as summarized by the
Merck diagnostic guidance.
Management principles
1. Treat the cause
- Stop or adjust a causative medication when appropriate.
- Treat diarrhea, vomiting, endocrine disease, or renal losses.
- For recurrent diuretic-related hypokalemia, clinicians may adjust diuretic therapy, consider a potassium-sparing strategy when appropriate, and monitor potassium.
2. Replace potassium
- Oral potassium chloride is preferred for stable patients with a functioning gastrointestinal tract and potassium generally >2.5 mmol/L.
- IV potassium is used for severe hypokalemia, significant symptoms, ECG abnormalities, inability to take oral replacement, or ongoing severe losses.
- IV replacement requires careful rate limits, repeat measurements, and cardiac monitoring when aggressive replacement is used. Glucose-containing IV solutions are generally avoided during acute correction because insulin release can shift potassium into cells.
The
AAFP clinical review advises urgent treatment for potassium ≤2.5 mmol/L, ECG abnormalities, or neuromuscular symptoms, and prefers oral replacement when it is safe and feasible.
3. Recheck frequently
- Potassium can rebound, particularly when the apparent low value is due to a transcellular shift rather than true depletion.
- Be particularly cautious in chronic kidney disease or reduced urine output because replacement can lead to hyperkalemia.
When it is an emergency
Seek urgent clinical assessment for:
- Potassium ≤2.5 mmol/L
- Palpitations, fainting, chest discomfort, or an abnormal ECG
- Severe weakness, paralysis, or breathing difficulty
- Significant heart disease, digoxin therapy, or rapidly falling potassium
- Persistent vomiting/diarrhea or inability to take oral fluids
Key takeaway
Hypokalemia is most often due to renal or gastrointestinal potassium loss, but insulin, beta-agonists, alkalosis, and periodic paralysis can cause a rapid cellular shift. The priorities are to identify cardiac or neuromuscular danger, check and correct magnesium, determine whether potassium losses are renal, replace potassium safely, and address the underlying cause.